A Study on the Outcome and Its Influencing Factors in Patients With Borderline Personality Disorder
NCT ID: NCT06005779
Last Updated: 2023-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
270 participants
OBSERVATIONAL
2021-10-22
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder
NCT05381649
Delving Into Borderline Personality Disorder Clinical Trial Experiences
NCT05989529
Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study
NCT07247344
Event Related Potentials in Borderline Personality Disorder and Major Depression
NCT01469663
Establish a Specific Cohort Database for Depressive Disorders
NCT05095662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cox Proportional Hazard Model is used to analyze the influencing factors of remission of BPD, and Generalized Estimating Equation Model is used to analyze the influencing factors of the patients' social function and quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Comorbidity with neurological diseases such as epilepsy
* Comorbidity with mental retardation
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuhan Mental Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fan Yang, Master
Role: STUDY_DIRECTOR
Wuhan Mental Health Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan Mental Health Centre
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY2018.77
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.